PUBLISHER: The Business Research Company | PRODUCT CODE: 1994761
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994761
Robotic assisted endovascular systems are advanced medical solutions developed to assist and improve endovascular procedures through highly precise robotic control mechanisms. These systems combine robotic arms, imaging systems, navigation technologies, and operator consoles to support minimally invasive vascular interventions with greater accuracy and stability. They help decrease procedural complexity, enhance safety, and improve overall clinical results.
The major components of robotic-assisted endovascular systems include hardware, software, and services. Hardware refers to the physical robotic devices and instruments used in endovascular procedures, including catheters, guidewires, and angioplasty systems designed to enhance precision, control, and safety. These systems encompass products such as robotic catheter systems, robotic guidewire systems, robotic angioplasty systems, and other devices, utilizing technologies like AI-assisted navigation, imaging-guided robotic platforms, haptic feedback systems, and autonomous robotic systems. They are applied in coronary interventions, peripheral vascular interventions, neurovascular interventions, and other procedures, serving end-users such as hospitals, specialty clinics, ambulatory surgical centers, and research or academic institutions.
Tariffs on robotic control units, catheter robotics hardware, and imaging integration modules are raising procurement costs in the robotic assisted endovascular systems market. Import duties on precision actuators and navigation consoles are impacting system pricing and upgrade cycles. Hospitals in north america and europe that depend on imported robotic platforms are the most affected. Coronary and neurovascular intervention segments see the highest exposure due to advanced hardware requirements. At the same time, tariffs are encouraging regional manufacturing and localized component sourcing. Vendors are building partnerships with domestic device suppliers. This improves supply continuity while increasing short term capital costs.
The robotic assisted endovascular systems market research report is one of a series of new reports from The Business Research Company that provides robotic assisted endovascular systems market statistics, including robotic assisted endovascular systems industry global market size, regional shares, competitors with a robotic assisted endovascular systems market share, detailed robotic assisted endovascular systems market segments, market trends and opportunities, and any further data you may need to thrive in the robotic assisted endovascular systems industry. This robotic assisted endovascular systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The robotic assisted endovascular systems market size has grown strongly in recent years. It will grow from $32.01 billion in 2025 to $34.79 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increase in cardiovascular disease cases, growth in catheter based interventions, expansion of interventional radiology units, rising preference for minimally invasive surgery, improvements in vascular imaging.
The robotic assisted endovascular systems market size is expected to see strong growth in the next few years. It will grow to $48.94 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth in robotic vascular labs, rising demand for precision guided interventions, expansion of neurovascular robotic procedures, increasing remote surgery capabilities, higher hospital investment in robotic suites. Major trends in the forecast period include growth in robotic catheter navigation, rising adoption in minimally invasive vascular procedures, expansion of imaging guided robotic platforms, increasing use of remote robotic intervention, integration of precision vascular control systems.
The increasing prevalence of cardiovascular and neurovascular disorders is anticipated to drive the expansion of the robotic-assisted endovascular systems market in the coming years. Cardiovascular and neurovascular disorders are conditions that impact the heart, blood vessels, and cerebral circulation, including coronary artery disease, stroke, and cerebral aneurysms, and they remain a leading cause of death and long-term disability globally. The incidence of cardiovascular and neurovascular disorders is rising due to aging populations alongside higher rates of lifestyle-related risk factors such as obesity, hypertension, and sedentary behavior. Robotic-assisted endovascular systems aid in managing cardiovascular and neurovascular disorders by enabling highly precise, minimally invasive navigation of blood vessels, thereby enhancing treatment accuracy, safety, and clinical outcomes in complex vascular procedures. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular and neurovascular disorders is fueling the growth of the robotic-assisted endovascular systems market.
Key companies operating in the robotic assisted endovascular systems market are focusing on integrating robotics with advanced imaging and navigation systems, such as fully remote endovascular robotic platforms, to improve procedural precision, enable complex vascular navigation, and expand access to specialist care. Fully remote endovascular robotic platforms refer to robotic systems that combine real-time fluoroscopic imaging with preoperative CT and MRI data to guide robotic manipulation of catheters and guidewires during endovascular procedures while allowing clinicians to operate from a remote console. For example, in October 2025, Remedy Robotics, a US-based medical technology company, introduced the Remedy N1 System, an endovascular surgical robotic platform designed to support fully remote neurointerventional procedures. It is designed to enhance accuracy and clinical workflow, the system integrates automated CT and MRI image preprocessing with live fluoroscopic imaging for real-time navigation, enables simultaneous robotic control of up to four endovascular devices, and includes a portable operator console with secure audiovisual connectivity to support remote procedural execution.
In October 2025, Remedy Robotics Inc., a US-based healthcare technology firm specializing in robotic-assisted endovascular systems, collaborated with the Australian Stroke Alliance to deploy and implement robotic endovascular systems across hospitals nationwide, improving access to minimally invasive stroke and cardiovascular procedures. Through this collaboration, Remedy Robotics seeks to broaden access to advanced endovascular robotic interventions throughout Australia by integrating its robotic systems into the Stroke Alliance's national clinical network and hospital infrastructure, enhancing procedural efficiency, precision, and patient outcomes in stroke and cardiovascular treatment. The Australian Stroke Alliance is an Australia-based healthcare consortium of clinicians, researchers, and industry participants dedicated to advancing stroke care nationwide.
Major companies operating in the robotic assisted endovascular systems market are Johnson & Johnson, Siemens Healthineers AG, Corindus Vascular Robotics Inc., Cordis Corporation, MicroPort Scientific Corporation, Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.
Europe was the largest region in the robotic assisted endovascular systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic assisted endovascular systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the robotic assisted endovascular systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The robotic assisted endovascular systems market consists of sales of robotic arms and positioning mechanisms, imaging and navigation modules, control and operating software licenses, sensors and actuators, and disposable and reusable endovascular instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Robotic Assisted Endovascular Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses robotic assisted endovascular systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for robotic assisted endovascular systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic assisted endovascular systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.